Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Buildings (2016)

Historic Buildings for Bio-Techne (TECH) over the last 7 years, with Q2 2016 value amounting to $158.0 million.

  • Bio-Techne's Buildings rose 63.58% to $158.0 million in Q2 2016 from the same period last year, while for Jun 2016 it was $158.0 million, marking a year-over-year increase of 63.58%. This contributed to the annual value of $158.0 million for FY2016, which is 63.58% up from last year.
  • Bio-Techne's Buildings amounted to $158.0 million in Q2 2016, which was up 63.58% from $157.0 million recorded in Q2 2015.
  • Bio-Techne's 5-year Buildings high stood at $158.0 million for Q2 2016, and its period low was $122.7 million during Q1 2012.
  • For the 5-year period, Bio-Techne's Buildings averaged around $142.1 million, with its median value being $146.3 million (2013).
  • As far as peak fluctuations go, Bio-Techne's Buildings surged by 1627.33% in 2013, and later surged by 63.58% in 2016.
  • Bio-Techne's Buildings (Quarter) stood at $133.0 million in 2012, then rose by 10.98% to $147.7 million in 2013, then rose by 4.12% to $153.7 million in 2014, then increased by 2.11% to $157.0 million in 2015, then increased by 0.64% to $158.0 million in 2016.
  • Its Buildings stands at $158.0 million for Q2 2016, versus $157.0 million for Q2 2015 and $153.7 million for Q3 2014.